NV Pharma Capital Partners 01 LLC is a private equity fund based in Houston, Texas. According to its most recent Form D, filed Apr 8, 2019, it has sold $5,605,995 of interests to 3 investors since its first sale in Apr 2019. The minimum investment it accepts from an outside investor is $500,000. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Thomas Krenik; Kelley Rytlewski.
- Total raised
- $5,605,995Cumulative sales reported on Form D
- Investors
- 3
- First sale
- Apr 8, 2019
- Minimum investment
- $500,000
- Who can invest
- Not stated
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Thomas Krenik; Kelley Rytlewski
- Latest Form D
- Apr 8, 2019
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Apr 8, 2019 | Form D | $5,605,995 | 3 | SEC.gov ↗ |
| May 21, 2018 | Form D | $2,227,727 | 1 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on May 21, 2018. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about NV Pharma Capital Partners 01 LLC
What is the minimum investment for NV Pharma Capital Partners 01 LLC?
According to its latest Form D, filed Apr 8, 2019, the minimum investment NV Pharma Capital Partners 01 LLC accepts from an outside investor is $500,000.
Who can invest in NV Pharma Capital Partners 01 LLC?
NV Pharma Capital Partners 01 LLC is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(b), which does not allow general advertising.
How much has NV Pharma Capital Partners 01 LLC raised?
NV Pharma Capital Partners 01 LLC reports $5,605,995 sold from 3 investors on its Form D filed Apr 8, 2019. This is cumulative sales since the offering began, not current assets or performance.
Where is NV Pharma Capital Partners 01 LLC based?
NV Pharma Capital Partners 01 LLC is based in Houston, Texas.
When did NV Pharma Capital Partners 01 LLC launch?
NV Pharma Capital Partners 01 LLC reports its first sale in Apr 2019.
Size compared with every private equity fund
Raised more than 62% of the 1,394 private equity funds based in Texas, and more than 37% of all 8,975 that report sales.